ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 135 filers reported holding ARCUS BIOSCIENCES INC in Q2 2021. The put-call ratio across all filers is 4.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $986,370 | -9.6% | 54,951 | +2.3% | 0.01% | -11.1% |
| Q2 2023 | $1,091,398 | +24.4% | 53,737 | +11.7% | 0.01% | +12.5% |
| Q1 2023 | $877,344 | -13.0% | 48,100 | -1.4% | 0.01% | -11.1% |
| Q4 2022 | $1,008,667 | -2.1% | 48,775 | +23.9% | 0.01% | -10.0% |
| Q3 2022 | $1,030,000 | -4.5% | 39,375 | -7.5% | 0.01% | 0.0% |
| Q2 2022 | $1,078,000 | -53.2% | 42,549 | -41.7% | 0.01% | -60.0% |
| Q1 2022 | $2,305,000 | -29.9% | 73,040 | -10.2% | 0.02% | -32.4% |
| Q4 2021 | $3,290,000 | +7.8% | 81,295 | -7.1% | 0.04% | +27.6% |
| Q3 2021 | $3,051,000 | +18.8% | 87,503 | -6.4% | 0.03% | +26.1% |
| Q2 2021 | $2,568,000 | -22.1% | 93,506 | -20.4% | 0.02% | -28.1% |
| Q1 2021 | $3,298,000 | +8.3% | 117,451 | +0.1% | 0.03% | -5.9% |
| Q4 2020 | $3,046,000 | – | 117,318 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |